The track & trace big question: Can we get around aggregation? Or should we get ready?


Implementing ‘aggregation’ – the term used to describe pharmaceutical product unit-to-case hierarchy – is not mandatory in Europe, however industry delegates say there is incentive to push its adoption. 

Image: GettyImages/PeterHermesFurian

Roche Spanish plant becomes eighth solid dose site for Recipharm

Cook site in Bloomington

Catalent to buy Cook Pharmica for $950m in cash

Image: iStock/naruedom

Recipharm to make clinical trial cancer candidate for Kancera

(Image: iStock/Golden_Brown)

CordenPharma completes early development suite at Plankstadt facility

New Fujifilm mAb lab at the Wilton Centre (source Wilton Centre website)

Fujifilm Diosynth Biotechnologies opens new UK lab


Catalent to make opioid withdrawal candidate for US approval


Ageing facilities & drug shortages: industry concern drives guidance for manufacturers


Asian innovation: Big Pharma’s push to modernise manufacturing

Image c/o Google Streetview

Roche sells Italian formulations plant to CMO Delpharm

More Processing